Epigenetic reprogramming as a key contributor to melanocyte malignant transformation

References

• Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457 - 463
   PubMed Web of Science ®Google Scholar
• Ehrlich M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 2002; 132:2424 - 2429
   PubMed Web of Science ®Google Scholar
• Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB, et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77:833 - 838
   PubMed Web of Science ®Google Scholar
• Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489 - 492
   PubMed Web of Science ®Google Scholar
• Wu J, Issa JP, Herman J, Bassett DE Jr, Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 1993; 90:8891 - 8895
   PubMed Web of Science ®Google Scholar
• Robertson KD, Uzvolgyi E, LIang G, Talmadge C, Sumegi J, Gonzales FA, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27:2291 - 2298
   PubMed Web of Science ®Google Scholar
• Wang YA, Kamarova Y, Shen KC, Jiang Z, Hahn MJ, Wang Y, et al. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression. Cancer Biol Ther 2005; 4:1138 - 1143
   PubMed Web of Science ®Google Scholar
• Chi P, Allis CD, Wang GG. Covalent histone modifications: miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010; 10:457 - 469
   PubMed Web of Science ®Google Scholar
• Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295 - 304
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315 - 326
   PubMed Web of Science ®Google Scholar
• Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448:553 - 560
   PubMed Web of Science ®Google Scholar
• Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447:425 - 432
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21 - 33
   PubMed Web of Science ®Google Scholar
• Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299:1753 - 1755
   PubMed Web of Science ®Google Scholar
• Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nature Genet 1994; 7:536 - 540
   PubMed Web of Science ®Google Scholar
• Baylin SB, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction?. Nat Rev Cancer 2006; 6:107 - 116
   PubMed Web of Science ®Google Scholar
• Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007; 115:1161 - 1176
   PubMed Web of Science ®Google Scholar
• Houghton AN, Polsky D. Focus on melanoma. Cancer cell 2002; 2:275 - 278
   PubMed Web of Science ®Google Scholar
• Oba-Shinjo SM, Correa M, Ricca TI, Molognoni F, PInhal MA, Neves IA, et al. Melanocyte transformation associated with substrate adhesion impediment. Neoplasia 2006; 8:231 - 241
   PubMed Web of Science ®Google Scholar
• Ricca TI, Liang G, Suenaga AP, Han SW, Jones PA, Jasiulionis MG. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation. Transl Oncol 2009; 2:329 - 340
   PubMed Web of Science ®Google Scholar
• Silva AG, Graves HA, Guffei A, Ricca TI, Mortara RA, Jasiulionis MG, Mai S. Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia 2010; 12:11 - 19
   PubMed Web of Science ®Google Scholar
• Campos AC, Molognoni F, Melo FH, Galdieri LC, Carneiro CR, D'Almeida V, et al. Oxidative stress modulates DNA methylation by endogenous nitric oxide during cell substrate adhesion blockade. Neoplasia 2007; 9:1111 - 1121
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation, methyltransferases and cancer. Oncogene 2001; 20:3139 - 3155
   PubMed Web of Science ®Google Scholar
• Guz J, Foksinski M, Olinski R. Global DNA hipomethylation: the meaning in carcinogenesis. Postepy Biochem 2010; 56:16 - 21
   PubMedGoogle Scholar
• McCabe MT, Davis JN, Day ML. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 2005; 65:3624 - 3632
   PubMedGoogle Scholar
• Bogdanovic O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009; 118:549 - 565
   PubMed Web of Science ®Google Scholar
• Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 2008; 27:2681 - 2690
   PubMed Web of Science ®Google Scholar
• Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, et al. Suv39 h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003; 13:1192 - 1200
   PubMed Web of Science ®Google Scholar
• Bapat SA, Jin V, Berry N, Balch C, Sharma N, Kurrey N, et al. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. Epigenetics 2010; 5:716 - 712
   PubMed Web of Science ®Google Scholar
• Pinskaya M, Morillon A. Histone H3 lysine 4 dimethylation: a novel mark for transcriptional fidelity?. Epigenetic 2009; 4:302 - 306
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074 - 1080
   PubMed Web of Science ®Google Scholar
• Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008; 647:21 - 29
   PubMed Web of Science ®Google Scholar
• Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 2010; 1804:1684 - 1689
   PubMed Web of Science ®Google Scholar
• Persson J, Ekwall K. Chd1 remodelers maintain open chromatin and regulate the epigenetics of differentiation. Exp Cell Res 2010; 316:1316 - 1323
   PubMed Web of Science ®Google Scholar
• Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004; 20:350 - 358
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. Cancer prevention research—then and now. Nat Rev Cancer 2009; 9:508 - 516
   PubMed Web of Science ®Google Scholar
• Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk: a systematic. Int J Cancer 2009; 125:491 - 524
   PubMed Web of Science ®Google Scholar
• Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009; 23:383 - 395
   PubMed Web of Science ®Google Scholar
• Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295 - 304
   PubMed Web of Science ®Google Scholar
• Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005; 26:1856 - 1867
   PubMed Web of Science ®Google Scholar
• Muthusamy V, Duraisamy S, Bradbury CM, Hobbs C, Curley DP, Nelson B, et al. Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res 2006; 66:11187 - 11193
   PubMed Web of Science ®Google Scholar
• Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, et al. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Invest Ophthalmol Vis Sci 2003; 44:2390 - 2398
   PubMed Web of Science ®Google Scholar
• van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, et al. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 2003; 106:472 - 479
   PubMed Web of Science ®Google Scholar
• Marini A, Mirmohammadsadegh A, Nambiar S, Gustrau A, Ruzicka T, Hengge UR. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma. J Invest Dermatol 2006; 126:422 - 431
   PubMed Web of Science ®Google Scholar
• Liu S, Ren S, Howell P, Fodstad O, Riker AI. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res 2008; 21:545 - 558
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in cancer onset and progression. Bull Acad Natl Med 2009; 193:1969 - 1678
   PubMed Web of Science ®Google Scholar
• Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009; 13:863 - 868
   Google Scholar
• Sims RJ 3rd, Reinberg D. Stem cells: Escaping fates with open states. Nature 2009; 13:802 - 803
   Web of Science ®Google Scholar
• Szutorisz H, Georgiou A, Tora L, Dillon N. The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 2006; 127:1375 - 1388
   PubMed Web of Science ®Google Scholar
• Calvanese V, Lara E, Suárez-Alvarez B, Abu Dawud R, Vázquez-Chantada M, Martínez-Chantar ML, et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci USA 2010; 107:13736 - 13741
   PubMed Web of Science ®Google Scholar
• Bjelland S, Seeberg E. Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat Res 2003; 531:37 - 80
   PubMed Web of Science ®Google Scholar
• Escargueil AE, Soares DG, Salvador M, Larsen AK, Henriques JA. What histone code for DNA repair?. Mutat Res 2008; 658:259 - 270
   PubMed Web of Science ®Google Scholar
• Smerdon MJ. DNA repair and the role of chromatin structure. Curr Opin Cell Biol 1991; 3:422 - 428
   PubMed Web of Science ®Google Scholar
• Amouroux R, Campalans A, Epe B, Radicella JP. Oxidative stress triggers the preferential assembly of base excision repair complexes on open chromatin regions. Nucleic Acids Res 2010; 38:2878 - 2890
   PubMed Web of Science ®Google Scholar
• Costes SV, Chiolo I, Pluth JM, Barcellos-Hoff MH, Jakob B. Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization. Mutat Res 2010; 704:78 - 87
   PubMed Web of Science ®Google Scholar
• Suter B, Livingstone-Zatchej M, Thoma F. Chromatin structure modulates DNA repair by photolyase in vivo. EMBO J 1997; 16:2150 - 2160
   PubMed Web of Science ®Google Scholar
• O'Hagan HM, Mohammad HP, Baylin SB. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet 2008; 4:1000155
   PubMed Web of Science ®Google Scholar
• Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 1987; 39:414 - 418
   PubMed Web of Science ®Google Scholar
• Gonzalgo ML, Jones PA. Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE). Methods 2002; 27:128 - 133
   PubMed Web of Science ®Google Scholar